Atrial Fibrillation Patient Recruitment in New York

TheraNovex connects clinical trial sponsors with pre-screened, eligible Atrial Fibrillation patients across New York, including New York City, Buffalo, Rochester, and beyond.

Atrial fibrillation patient recruitment for paroxysmal, persistent, and permanent AF clinical trials.

Who qualifies: Adults with paroxysmal, persistent, or long-standing persistent AF, including anticoagulation-naive patients.

Recruitment challenges: CHA₂DS₂-VASc score requirements and prior antiarrhythmic therapy eligibility.

Our approach: Electrophysiology and cardiology referral networks with Holter monitoring pre-screening.

Our recruitment network spans all major metropolitan areas in New York, ensuring broad geographic coverage for your Atrial Fibrillation trial.